ADRB3 Polymorphism Associated with BMI Gain in Japanese Men by Takeuchi, Shouhei et al.
Hindawi Publishing Corporation
Experimental Diabetes Research
Volume 2012, Article ID 973561, 5 pages
doi:10.1155/2012/973561
Clinical Study
ADRB3 PolymorphismAssociatedwith
BMI Gain in Japanese Men
Shouhei Takeuchi,1 Takahiko Katoh,2 Takenori Yamauchi,1 and Yoshiki Kuroda1
1Department of Public Health, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
2Department of Public Health, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjou, Kumamoto 860-8556, Japan
Correspondence should be addressed to Yoshiki Kuroda, ykuroda@med.miyazaki-u.ac.jp
Received 11 November 2011; Revised 21 January 2012; Accepted 3 February 2012
Academic Editor: Toshiyasu Sasaoka
Copyright © 2012 Shouhei Takeuchi et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Objective.TheaimofthisstudywastoevaluatetheassociationbetweentheTrp64Argpolymorphisminthebeta3-adrenergicrecep-
tor gene (ADRB3: rs4994) and BMI and serological and anthropometric data in healthy Japanese. Methods. Healthy Japanese re-
cruitedinalarge-scaleintegratedmanufacturingfacilityinJapan(N = 1355;age:37.25 ±9.43;BMI:22.86 ±3.46)wereeligiblefor
analysis. The anthropometric data and serological data were measured during a comprehensive health check, and a self-reporting
questionnaire was used to assess lifestyle habits (current exercise, smoking status, alcohol intake, and working style) and weight at
age 20. Genotyping for the ADRB3 polymorphism was performed by PCR-RFLP method. Results. Among 1355 participants, the
genotypefrequenciesoftheTrp/Trp,Trp/Arg,andArg/Argvariantswere920(67.9%),394(29.1%),and41(3.05%),respectively.In
the multivariate analysis, a multiple linear regression model in men for the adjustment of age, drinking habits, smoking habits,
exercise habits, working status and serological measurements statistically showed an overall weak signiﬁcance between annual BMI
gain from age 20 and age, LDL or ADRB3 polymorphism. Conclusions.T h el e v e lo fL D L ,a g e ,a n dADRB3 polymorphism (Arg/Arg
genotype) were statistically associated with annual BMI gain in Japanese men.
1.Introduction
Thebeta3-adrenergicreceptor(ADRB3)isprimarilyexpress-
ed in adipose tissue [1] and is involved in the regulation of
energymetabolism.In1995,threereportsrelatedtothepoly-
morphism of ADRB3 in codon 64 (Trp64Arg: rs4994) were
published. They reported that early development of type 2
diabetes mellitus, lower resting metabolic rate, abdominal
obesity, and resistance to insulin were associated with per-
sons homozygous for the variant allele (Arg/Arg) compared
to those homozygous for the wild-type allele (Trp/Trp) and
those heterozygous for the variant allele (Trp/Arg) [2–6].
Pi´ etri-Rouxel et al. showed that in human HEK293 cells with
ADRB3 variant allele, the reduction in cAMP accumulation
in response to beta3-adrenergic agonists resulted in decreas-
ed lipolysis and thermogenesis [7]. Umekawa et al. also
showedthatADRB3variantwasassociatedwithlowerlipoly-
tic activities in human omental adipocytes [8]. Therefore, an
impairment of ADRB3 may lead to obesity through the
energy expenditure reduction of fat tissue. This allowed us to
accept ADRB3 as a candidate gene for obesity [9, 10].
However, the association between BMI gain and the
ADRB3 polymorphism is still controversial. The meta-anal-
yses indicated that there was an association between BMI
and the ADRB3 polymorphism among an obese population
[11] and among obese and normal populations [12]. Con-
versely, several studies [13, 14] suggested that there was no
association between BMI and the ADRB3 polymorphism.
The aim of this study was to evaluate the inﬂuence of ADRB3
polymorphism on BMI and serological and anthropometric
data in healthy Japanese.
2.SubjectsandMethods
2.1. Subjects. The participants were recruited from employ-
ees working at a large-scale integrated manufacturing facility
in Japan, and their routine medical checkup data were used2 Experimental Diabetes Research
for the analysis. Of the 1401 participants, only the workers
who were out of work or who had serious symptoms were
excluded from this study, 1355 agreed to participate in the
presentstudywithinformedconsent,1074(77%)weremales
and 284 (20%) were females. We analyzed the ADRB3 poly-
morphism, lifestyle habits, and anthropometric data (2 men
and a woman had missing data) for the participants. Their
ages ranged from 18 to 65 years (mean: 37.3 ± 9.4y e a r s ) .
During a comprehensive health check, the following anthro-
pometric data and serological data were measured: height,
weight, systolic blood pressure (SBP), diastolic blood pres-
sure (DBP), GOT, GPT, γ-GTP, total cholesterol, low-density
lipoprotein cholesterol (LDL) and high-density lipoprotein
cholesterol (HDL), and triglyceride. For the lifestyle assess-
ment,currentexercise(no,1-2days/week,or3–7days/week),
smoking status (no, 1–20 cigarettes/day, or more than 20
cigarettes/day), alcohol intake (no, sometimes, or every day),
workingstyle(havingnightshiftornot),andweightatage20
were obtained through a self-reporting questionnaire. Body
mass index (BMI) was calculated as weight (in kilograms)
divided by height (in meters) squared. We followed the Ethi-
cal Guideline for Human Genome/Gene Analysis Research
endorsed by the Japanese government. The study protocol
was approved by the ethics committee of University of Miya-
zaki Graduate School of Medical Sciences, and all subjects
provided written informed consent.
2.2. Genotyping. Genomic DNA was extracted from peri-
pheral blood leukocytes by using a DNA Extractor WB Kit
(Wako Pure Chemical Industries, Osaka, Japan). Ampliﬁca-
t i o no fD N Ab yp o l y m e r a s ec h a i nr e a c t i o nw a sc a r r i e do u t
to analyze for the Trp64Arg polymorphism with the primer
(sense: 5 -CGCCCAATACCGCCAACAC-3  ,a n t i s e n s e :5  -
CCACCAGGAGTCCCATCACC-3  ) under the same pro-
cedure described by Widen et al. with the restriction enzyme
Mva I [4]. The ampliﬁed fragments of 210bp were digested
with Mva I and analyzed by 3% agarose-gel electrophoresis.
The fragment size was judged as the Arg/Arg type if 161 base
pairs; the Trp/Trp type if 99 and 62 base pairs; the Trp/Arg
type if 161, 99, and 62 base pairs.
2.3. Statistical Analysis. Results are presented as mean ±
standard deviation (SD), and categorical variables are ex-
pressed as numbers counted. All analyses were performed
stratiﬁed by sex due to the diﬀerence in number of male and
female participants. The exact test was used to verify Hardy-
Weinberg equilibrium of genotype frequencies. The analysis
of variance (ANOVA) or Kruskal-Wallis rank sum test was
used to access the diﬀerences among ADRB3 gene polymor-
phism. Multivariate analysis for adjusting age, sex, current
exercise, alcohol intake, working style, and smoking habits
was performed by multiple linear regression analysis. The
level of statistical signiﬁcance was set at P<. 05. All analyses
were performed using R version 2.12.2.
3. Results
Genotyping of the ADRB3 polymorphism in the 1355 parti-
cipants showed that those homozygous for the wild-type
Table 1: Sociodemographic information and lifestyle habits strati-
ﬁed by ADRB3 polymorphism.
Trp64Trp Trp64Arg Arg64Arg
N 920 394 41
Age 37.31 ±9.29 37.27 ±9.66 35.61 ±10.38
Sex Male 719 320 33
Female 201 74 8
BMI
(kg/m2) 22.86 ±3.49 22.91 ±3.44 22.28 ±2.88
Smoking
status
No 450 191 15
20
cigarettes 381 172 20
21
cigarettes 89 31 6
Current
exercise
No 591 217 25
1-2
days/week 261 144 12
3–7
days/week 68 33 4
Working
style
Having
shift work 489 211 25
Not having
shift work 431 183 16
All variables did not associate with the ADRB3 polymorphism.
allele(Trp/Trp)were920(67.9%),thoseheterozygousforthe
variant allele (Arg/Trp) were 394 (29.1%), and those homo-
zygous for the variant allele (Arg/Arg) were 41 (3.0%). These
results were in the Hardy-Weinberg equilibrium and did not
conﬂict with the results previously reported in another Japa-
nese population (P = .93).
The demographic characteristics and lifestyle habits of
the participants stratiﬁed by the genotype of the ADRB3
polymorphism are presented in Table 1. Among all partici-
pants, the mean age was 37.25 ± 9.43 (mean ± SD) and the
mean BMI was 22.86 ± 3.46 (mean ± SD). There were no
signiﬁcant diﬀerences with age and BMI in each stratiﬁed
group. We also divided participant data into categories based
on sex, smoking status, current exercise, and working style.
In each category, the distributions of the genotypes were not
diﬀerent from the results previously reported in another
Japanese population.
The serological test results of the participants are shown
in Table 2. There was no association between these serolog-
ical results and the genotype of the ADRB3 polymorphism
(ANOVA and Kruskal-Wallis rank sum test).
A multiple linear regression model for the adjustment
of age, sex, alcohol intake, smoking status, current exercise,
working status, LDL, and ADRB3 polymorphism (Table 3)
showed an overall weak model for predicting annual BMI
gain(thedegreeofBMIincrease)fromage20peryearbyage,
smoking status, LDL, and Arg/Arg genotype. To avoid the
bias caused by the diﬀerence in number of male and female
participants, data were stratiﬁed by sex and analyzed sepa-
rately. There were statistically signiﬁcant associations in male
betweenthegenotypeoftheADRB3polymorphism,age,andExperimental Diabetes Research 3
Table 2: Serological variables stratiﬁed by the ADRB3 polymor-
phism.
Trp64Trp Trp64Arg Arg64Arg
SBP (mmHg) 121.93 ±14.47 122.23 ±13.82 118.24 ±12.17
DBP (mmHg) 73.72 ±11.17 74.27 ±11.74 72.78 ±8.6
GOT (IU/l) 21.51 ±10.52 21.37 ±9.13 20.73 ±8.54
GPT (IU/l) 29.32 ±23.91 29.47 ±20.52 6 .49 ±16.42
LDL (mg/dL) 111.57 ±30.64 111.85 ±32.5 105.66 ±27.55
HDL (mg/dL) 58.64 ±13.79 59.54 ±14.79 56.16 ±11.9
TG (mg/dL) 139.6 ±126.84 138.48 ±116.33 138.1 ±84.91
No signiﬁcant diﬀerence among the ADRB3 polymorphism was found in
each serological variable.
Table 3: Multiple regression analysis for annual BMI gain and var-
iables.
Estimate SE t value Pr(> |t|)
Intercept 0.171 0.096 1.788 0.075
Age −0.000 0.000 −2.241 0.026∗
Sex 0.014 0.060 0.233 0.816
Alcohol intake 0.000 0.000 −0.286 0.776
Current exercise −0.000 0.028 −0.338 0.736
Working style 0.013 0.037 0.359 0.720
Smoking status −0.057 0.028 −2.053 0.041∗
ADRB3
(Trp/Arg)
−0.000 0.037 −0.078 0.938
ADRB3
(Arg/Arg) 0.216 0.082 2.626 0.009∗∗
LDL 0.000 0.000 3.449 <0.001∗∗
From the stepwise multiple regression analysis, age, sex, alcohol intake,
current exercise, working style, smoking status, LDL, and the ADRB3 poly-
morphism were selected for the ﬁnal model of the predictor of BMI gain,
adjusted R2 = .0796 (F-statistic = 2.874, P<. 01).
Table 4: Multiple regression analysis for annual BMI gain and var-
iables in Japanese men.
Estimate SE t value Pr(> |t|)
Intercept 0.193 0.097 1.998 0.047∗
Age −0.005 0.002 −2.326 0.021∗
Alcohol intake 0.000 0.000 −0.649 0.517
Current exercise 0.002 0.027 0.067 0.947
Working style 0.001 0.038 0.015 0.988
Smoking status −0.053 0.028 −1.883 0.061
ADRB3
(Trp/Arg) 0.009 0.038 0.227 0.821
ADRB3
(Arg/Arg) 0.218 0.079 2.761 0.006∗∗
LDL 0.002 0.001 3.245 0.001∗∗
From the stepwise multiple regression analysis, age, alcohol intake, current
exercise,workingstyle,smokingstatus,LDL,andtheADRB3polymorphism
were selected for the ﬁnal model of the predictor of BMI gain, adjusted
R2 = .092 (F-statistic = 3.224, P<. 01).
LDL and the annual BMI gain (Table 4), and there was no
statistically signiﬁcant association in female (Table 5).
Table 5: Multiple regression analysis for annual BMI gain and var-
iables in Japanese women.
Estimate SE t value Pr(> |t|)
Intercept −0.421 0.474 −0.888 0.392
Age 0.004 0.012 0.363 0.723
Alcohol intake 0.000 0.000 0.486 0.636
Current exercise −0.357 0.263 −1.356 0.200
Working style 0.147 0.153 0.958 0.357
Smoking status 0.057 0.183 0.309 0.763
ADRB3
(Trp/Arg) 0.127 0.256 0.497 0.628
LDL 0.005 0.003 1.746 0.106
From the stepwise multiple regression analysis, age, alcohol intake, current
exercise,workingstyle,smokingstatus,LDL,andtheADRB3polymorphism
were selected for the ﬁnal model of the predictor of BMI gain, adjusted
R2 =− .078 (F-statistic = .803, P>. 05).
4. Discussion
The eﬀects of ADRB3 polymorphism were reported in 1995
[2–4]. The potential for weight gain among the population
having the Trp/Arg mutation of the ADRB3 gene has been
suggested [2]. It wasthought that the variant allele (Arg/Arg)
had lower lipolytic activities and induced heavier weight
[15]. In the present study, we analyzed the relationship bet-
ween annual BMI gain and the ADRB3 polymorphism in
Japanese young men who are generally healthy. In the multi-
variate analysis, the ADRB3 genotype (Arg/Arg), age, and
LDL were associated with annual BMI gain. This result indi-
cated that the annual BMI gain was increased with Arg/Arg
genotype compared to Trp/Trp genotype, and high LDL was
also related to increased annual BMI gain. The high LDL,
however, could not be thought to be the cause of the annual
BMI gain. Therefore, the high LDL was thought to be a result
of increased body weight.
On the other hand, our results indicated that the ADRB3
polymorphism was not associated with current BMI. The
relationship between the ADRB3 polymorphism and current
BMI has been controversial. Shiwaku et al. [16], Tahara et al.
[17], Witchel et al. [18], and Matsushita et al. [14]r e p o r t e d
that the ADRB3 polymorphism and BMI have not associated
signiﬁcantly with each other. Conversely, Oizumi et al. [15]
pointed out that the Arg/Arg genotype was associated with
obesity and current BMI. There were meta-analysis studies
concerning the ADRB3 polymorphism and obesity [11, 12]
which indicated that Arg/Arg genotype led to increased body
weight. These previous studies seem to lead the hypothesis
that the ADRB3 polymorphism is associated with current
BMI and suggest that the ADRB3 polymorphism could be
a genetic predictor of increased body weight. However, there
still have been confounding factors that induced obesity and
overweight such as lack of exercise, over intake of energy, and
predisposition of other genes. These confounders could be
one reason why the relationship between the ADRB3 poly-
morphism and BMI is still controversial.
While Matsuo et al. [19] indicated that BMI for older
adults (60–79-year-age group) was higher than that of4 Experimental Diabetes Research
middle-aged adults (40–59-year-age group), other reports
showed that BMI gain is more severe in middle age than old
age [20–22]. Berg et al. [20] indicated that the largest in-
creases in obesity and overweight were in young people. On
the other hand, the eﬀects of genetic predisposition on diﬀe-
rence in body weight might exist to a greater extent among
middle aged than older adults [23]. The present study also
indicated that annual BMI gain was greater with Arg/Arg
genotype compared to Trp/Trp in younger men (the mean
agewas37.25±9.43).Matsushitaetal.[14]suggestedlittleor
no inﬂuence of the ADRB3 polymorphism on BMI gain in
their report. However their mean age was older than that
of the present study. BMI gain (the degree of BMI increase)
might be thought to be more suitable to evaluate the rela-
tion between the ADRB3 polymorphism and body weight
inﬂuence, and the time for evaluation of BMI gain related to
the ADRB3 polymorphism was more suitable in the younger
group.
In the present study, we had some limitations. One of
them was that our data might include the information bias
because we used the questionnaire to get the weight at age
20. We believed that the body weights in the questionnaire
were not so diﬀerent from true weight at age 20 because
many people can remember their weight at age 20. However,
caution was needed in evaluating this data for female parti-
cipants, as women tended to reply lighter weight. Another
wasthelackofcheckingtheplasmaglucose,HbA1c,andfast-
ing insulin data, even NIDDM was discussed in this article.
Obesity and overweight are associated with incidence
of diabetes. The Trp/Arg genotype of the ADRB3 polymor-
phismhasbeensaidtobeassociatedwithresistancetoinsulin
and may contribute to the early onset of NIDDM [3, 4]. We
have not evaluated the relationship between the incidence of
diabetes and the ADRB3 polymorphism. Considering that
Sasai et al. [24] showed that the eﬀects of BMI on diabetes
mellitus are greater among middle-aged than older adults,
andthepresentresultalsosuggeststhattheArg/Arggenotype
of ADRB3 polymorphism might be a risk factor for diabetes.
We also have not evaluated the eﬀects of exercise in rela-
tion to the ADRB3 polymorphism. The relationship between
the ADRB3 polymorphism and BMI change (gain or reduc-
tion) with health programs, including training or exercise,
has been controversial as well. The resistance to BMI redu-
ctioninthosewhohadthevariantalleleofADRB3afterexer-
cise or training was suggested by the ratio of visceral to sub-
cutaneous fat area after a 3-month weight reduction inter-
vention among women in their 40s and 50s [25]. However,
no resistance to BMI reduction in peoples who had the var-
iant allele of ADRB3 was reported [17, 26–28]. As an impor-
tant theme regarding the ADRB3 polymorphism, further
investigation into the relationship between ADRB3 and the
eﬀects of exercise on obesity is warranted.
5. Conclusion
In conclusion, ADRB3 polymorphism and high levels of LDL
were associated with annual BMI gain in men. On the other
hand, the present study did not indicate the same relation-
ship with ADRB3 polymorphism in women. Further studies
are needed to clarify the underlying mechanism between the
ADRB3 polymorphism and annual BMI gain and to evaluate
therelationshipbetweentheeﬀectofexerciseandtheADRB3
polymorphism.
Acknowledgments
The authors would like to thank the persons who were invol-
ved in the organization of the study and all the participants
of the study.
References
[1] S. Krief, F. Lonnqvist, S. Raimbault et al., “Tissue distribution
of β3-adrenergic receptor mRNA in man,” Journal of Clinical
Investigation, vol. 91, no. 1, pp. 344–349, 1993.
[2] K. Clement, C. Vaisse, B. S. J. Manning et al., “Genetic varia-
tionintheβ3-adrenergicreceptorandanincreasedcapacityto
gain weight in patients with morbid obesity,” New England
Journal of Medicine, vol. 333, no. 6, pp. 352–354, 1995.
[3] J. Walston, K. Silver, C. Bogardus et al., “Time of onset of non-
insulin-dependent diabetes mellitus and genetic variation in
the β3-adrenergic-receptor gene,” New England Journal of
Medicine, vol. 333, no. 6, pp. 343–347, 1995.
[4] E. Widen, M. Lehto, T. Kanninen, J. Walston, A. R. Shuldiner,
and L. C. Groop, “Association of a polymorphism in the β3-
adrenergic-receptorgenewithfeaturesoftheinsulinresistance
syndrome in ﬁnns,” New England Journal of Medicine,vol. 333,
no. 6, pp. 348–351, 1995.
[5] D .Corella,M.Guill´ en,O.Portol´ esetal.,“Genderspeciﬁcasso-
ciations of the Trp64Arg mutation in the β3-adrenergic recep-
tor gene with obesity-related phenotypes in a Mediterranean
population: interaction with a common lipoprotein lipase
gene variation,” Journal of Internal Medicine, vol. 250, no. 4,
pp. 348–360, 2001.
[6] K. Hao, S. Peng, H. Xing et al., “β3 adrenergic receptor poly-
morphismandobesity-relatedphenotypesinhypertensivepa-
tients,” Obesity Research, vol. 12, no. 1, pp. 125–130, 2004.
[7] F. Pi´ etri-Rouxel, B. St John Manning, J. Gros, and A. D. Stro-
sberg, “The biochemical eﬀect of the naturally occurring
Trp64→Arg mutation on human β3-adrenoceptor activity,”
European Journal of Biochemistry, vol. 247, no. 3, pp. 1174–
1179, 1997.
[8] T. Umekawa, T. Yoshida, N. Sakane, A. Kogure, M. Kondo,
and H. Honjyo, “Trp64Arg mutation of β3-adrenoceptor gene
deteriorates lipolysis induced by β3-adrenoceptor agonist in
human omental adipocytes,” Diabetes, vol. 48, no. 1, pp. 117–
120, 1999.
[9] T. Rankinen, A. Zuberi, Y. C. Chagnon et al., “The human ob-
esity gene map: the 2005 update,” Obesity,v o l .1 4 ,n o .4 ,p p .
529–644, 2006.
[10] K. Miyaki, S. Sutani, H. Kikuchi et al., “Increased risk of
obesity resulting from the interaction between high energy
intake and the Trp64Arg polymorphism of the β3-adrenergic
receptor gene in healthy Japanese men,” Journal of Epidemiol-
ogy, vol. 15, no. 6, pp. 203–210, 2005.
[ 1 1 ]N .K u r o k a w a ,K .N a k a i ,S .K a m e o ,Z .M .L i u ,a n dH .S a t o h ,
“Association of BMI with the β3-Adrenergic receptor gene
polymorphism in Japanese: meta-analysis,” Obesity Research,
vol. 9, no. 12, pp. 741–745, 2001.Experimental Diabetes Research 5
[ 1 2 ] T .F u j i s a w a ,H .Ik ega m i ,Y .K a w a g u c h i ,a n dT .O gi h a ra ,“ M et a -
analysis of the association of Trp64 arg polymorphism of β3-
adrenergicreceptorgenewithbodymassindex,”JournalofCli-
nical Endocrinology and Metabolism, vol. 83, no. 7, pp. 2441–
2444, 1998.
[13] J. Gagnon, P. Mauri` ege, S. Roy et al., “The Trp64Arg mutation
of the β3 adrenergic receptor gene has no eﬀect on obesity
phenotypes in the Quebec Family Study and Swedish Obese
Subjects cohorts,” Journal of Clinical Investigation, vol. 98, no.
9, pp. 2086–2093, 1996.
[14] Y. Matsushita, T. Yokoyama, N. Yoshiike et al., “The Trp64Arg
polymorphism of the β3-adrenergic receptor gene is not asso-
ciated with body weight or body mass index in Japanese: a
longitudinal analysis,” Journal of Clinical Endocrinology and
Metabolism, vol. 88, no. 12, pp. 5914–5920, 2003.
[15] T. Oizumi, M. Daimon, T. Saitoh et al., “Genotype Arg/Arg,
but not Trp/Arg, of the Trp64Arg polymorphism of the β3-
adrenergic receptor is associated with type 2 diabetes and ob-
esity in a large Japanese sample,” Diabetes Care,v o l .2 4 ,n o .9 ,
pp. 1579–1583, 2001.
[16] K. Shiwaku, A. Nogi, E. Anuurad et al., “Diﬃculty in losing
weight by behavioral intervention for women with Trp64Arg
polymorphism of the β3-adrenergic receptor gene,” Interna-
tional Journal of Obesity, vol. 27, no. 9, pp. 1028–1036, 2003.
[17] A. Tahara, Y. Osaki, and T. Kishimoto, “Eﬀe cto ft h eβ3-adren-
ergic receptor gene polymorphism Trp64Arg on BMI reduc-
tion associated with an exercise-based intervention program
in Japanese middle-aged males,” Environmental Health and
Preventive Medicine, vol. 15, no. 6, pp. 392–397, 2010.
[18] S. F. Witchel, J. Fagerli, J. Siegel et al., “No association between
body mass index and β3-adrenergic receptor variant (W64R)
in children with premature pubarche and adolescent girls with
hyperandrogenism,” Fertility and Sterility,v o l .7 3 ,n o .3 ,p p .
509–515, 2000.
[19] T. Matsuo, T. Sairenchi, H. Iso et al., “Age- and gender-speciﬁc
BMIintermsofthelowestmortalityinJapanesegeneralpopu-
lation,” Obesity, vol. 16, no. 10, pp. 2348–2355, 2008.
[20] C. Berg, A. Rosengren, N. Aires et al., “Trends in overweight
and obesity from 1985 to 2002 in G¨ oteborg, West Sweden,”
International Journal of Obesity, vol. 29, no. 8, pp. 916–924,
2005.
[21] A. Cook and B. Daponte, “A demographic analysis of the rise
in the prevalence of the US population overweight and/or
obese,” Population Research and Policy Review, vol. 27, no. 4,
pp. 403–426, 2008.
[22] D. Howel, “Trends in the prevalence of obesity and overweight
in English adults by age and birth cohort, 1991–2006,” Public
Health Nutrition, vol. 14, no. 1, pp. 27–33, 2011.
[23] A. J. Stunkard, T. I. A. Sorensen, and G. Hanis, “An adoption
studyofhumanobesity,”NewEnglandJournalofMedicine,vol.
314, no. 4, pp. 193–198, 1986.
[24] H. Sasai, T. Sairenchi, H. Iso et al., “Relationship between ob-
esity and incident diabetes in middle-aged and older Japanese
adults: the Ibaraki prefectural health study,” Mayo Clinic Pro-
ceedings, vol. 85, no. 1, pp. 36–40, 2010.
[25] M. Nakamura, M. Tanaka, S. Abe et al., “Association between
beta 3-adrenergic receptor polymorphism and a lower reduc-
tion in the ratio of visceral fat to subcutaneous fat area during
weight loss in Japanese obese women,” Nutrition Research, vol.
20, no. 1, pp. 25–34, 2000.
[26] T. Kahara, T. Takamura, T. Hayakawa et al., “Prediction of
exercise-mediated changes in metabolic markers by gene poly-
morphism,”DiabetesResearchandClinicalPractice,vol.57,no.
2, pp. 105–110, 2002.
[ 2 7 ]S .K u r i y a m a ,T .S h i m a z u ,A .H o z a w ae ta l . ,“ N oe ﬀect of the
T rp64Argvariantoftheβ3-adrenergicreceptorgeneonweight
loss by diet and exercise intervention among Japanese adults,”
Metabolism, vol. 57, no. 11, pp. 1570–1575, 2008.
[28] E. Morita, H. Taniguchi, and M. Sakaue, “Trp64Arg polymor-
phism in beta3-adrenergic receptor gene is associated with
decreased fat oxidation both in resting and aerobic exercise in
the Japanese male,” Experimental Diabetes Research, vol. 2009,
Article ID 605139, 5 pages, 2009.